Free Trial

Proto Labs (NYSE:PRLB) Stock Passes Above 200-Day Moving Average - Time to Sell?

Proto Labs logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Proto Labs crossed above its 200-day moving average, trading as high as $59.03 and last at $58.21 versus the 200‑day MA of $54.15 (50‑day MA $59.24) on volume of ~116,327 shares.
  • Fundamentals and analyst view: Q4 revenue of $136.49M and EPS $0.44 beat estimates (revenue +12.1% y/y) and management set Q1 2026 EPS guidance of $0.36–0.44, while the stock trades at a high P/E (~66) and carries a consensus "Buy" rating with a $53.33 target.
  • Insider and institutional activity: an insider sold 2,500 shares at $60, insiders own 1.7% of the stock and institutional investors hold about 84.5%, indicating heavy institutional ownership despite limited insider accumulation.
  • Five stocks to consider instead of Proto Labs.

Proto Labs, Inc. (NYSE:PRLB - Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $54.15 and traded as high as $59.03. Proto Labs shares last traded at $58.2110, with a volume of 116,327 shares trading hands.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Zacks Research upgraded shares of Proto Labs from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 11th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Proto Labs in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $53.33.

View Our Latest Research Report on PRLB

Proto Labs Stock Performance

The company has a market cap of $1.38 billion, a P/E ratio of 66.15 and a beta of 1.31. The business has a 50 day moving average price of $59.24 and a two-hundred day moving average price of $54.15.

Proto Labs (NYSE:PRLB - Get Free Report) last posted its quarterly earnings results on Friday, February 6th. The industrial products company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.09. Proto Labs had a return on equity of 3.19% and a net margin of 3.98%.The business had revenue of $136.49 million for the quarter, compared to analyst estimates of $129.07 million. During the same period last year, the company earned $0.38 EPS. Proto Labs's revenue for the quarter was up 12.1% compared to the same quarter last year. Proto Labs has set its Q1 2026 guidance at 0.360-0.440 EPS. As a group, research analysts expect that Proto Labs, Inc. will post 0.81 EPS for the current year.

Insider Activity at Proto Labs

In related news, insider Michael R. Kenison sold 2,500 shares of the company's stock in a transaction on Friday, February 6th. The shares were sold at an average price of $60.00, for a total transaction of $150,000.00. Following the completion of the sale, the insider directly owned 34,526 shares in the company, valued at $2,071,560. This represents a 6.75% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Proto Labs

A number of large investors have recently added to or reduced their stakes in PRLB. Hsbc Holdings PLC raised its stake in shares of Proto Labs by 45.4% during the fourth quarter. Hsbc Holdings PLC now owns 13,624 shares of the industrial products company's stock valued at $694,000 after acquiring an additional 4,253 shares during the last quarter. Auto Owners Insurance Co grew its stake in shares of Proto Labs by 4,959.0% in the fourth quarter. Auto Owners Insurance Co now owns 227,655 shares of the industrial products company's stock worth $11,517,000 after purchasing an additional 223,155 shares during the last quarter. Invesco Ltd. grew its stake in shares of Proto Labs by 5.2% in the fourth quarter. Invesco Ltd. now owns 107,698 shares of the industrial products company's stock worth $5,448,000 after purchasing an additional 5,364 shares during the last quarter. Summit Global Investments purchased a new position in Proto Labs during the 4th quarter valued at about $473,000. Finally, State of Tennessee Department of Treasury increased its holdings in Proto Labs by 82.1% during the 4th quarter. State of Tennessee Department of Treasury now owns 17,728 shares of the industrial products company's stock valued at $933,000 after purchasing an additional 7,995 shares during the period. Institutional investors own 84.54% of the company's stock.

Proto Labs Company Profile

(Get Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Proto Labs Right Now?

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines